Wesselingh SL - Search Results

1

Wright E, Brew BJ, Lal L, Ali ST, Arayawichanont A, Imran D, Kamarulzaman A, Kongsaengdao S, Kruy L, Merati TP, Samintharapanya K, Sarim C, Tau G, Thangsing C, Vin-Samnang C, Wesselingh SL. Wright E, et al. Among authors: wesselingh sl. Epilepsia. 2008 Mar;49(3):541-3. doi: 10.1111/j.1528-1167.2007.01529_5.x. Epilepsia. 2008. PMID: 18302631 Free article. No abstract available.

2

Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region.

Wright E, Brew B, Arayawichanont A, Robertson K, Samintharapanya K, Kongsaengdao S, Lim M, Vonthanak S, Lal L, Sarim C, Huffam S, Li P, Imran D, Lewis J, Lun WH, Kamarulzaman A, Tau G, Ali ST, Kishore K, Bain MP, Dwyer R, McCormack G, Hellard M, Cherry C, McArthur J, Wesselingh S. Wright E, et al. Neurology. 2008 Jul 1;71(1):50-6. doi: 10.1212/01.wnl.0000316390.17248.65. Neurology. 2008. PMID: 18591505

3

Pathogenesis and diagnosis of viral infections of the nervous system.

Wright EJ, Brew BJ, Wesselingh SL. Wright EJ, et al. Among authors: wesselingh sl. Neurol Clin. 2008 Aug;26(3):617-33, vii. doi: 10.1016/j.ncl.2008.03.006. Neurol Clin. 2008. PMID: 18657718

4

A report on the effect of commencing enfuvirtide on peripheral neuropathy.

Cherry CL, Duncan AJ, Mackie KF, Wesselingh SL, Brew BJ. Cherry CL, et al. Among authors: wesselingh sl. AIDS Res Hum Retroviruses. 2008 Aug;24(8):1027-30. doi: 10.1089/aid.2007.0300. AIDS Res Hum Retroviruses. 2008. PMID: 18724802

5

Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV.

Cherry CL, Affandi JS, Brew BJ, Creighton J, Djauzi S, Hooker DJ, Imran D, Kamarulzaman A, Kamerman P, McArthur JC, Moore RD, Price P, Smyth K, Tan IL, Vanar S, Wadley A, Wesselingh SL, Yunihastuti E. Cherry CL, et al. Among authors: wesselingh sl. Neurology. 2010 May 11;74(19):1538-42. doi: 10.1212/WNL.0b013e3181dd436d. Neurology. 2010. PMID: 20458071 Free PMC article.

6

Symptoms of depression and rates of neurocognitive impairment in HIV positive patients in Beijing, China.

Dwyer R, Wenhui L, Cysique L, Brew BJ, Lal L, Bain P, Wesselingh S, Wright EJ. Dwyer R, et al. J Affect Disord. 2014 Jun;162:89-95. doi: 10.1016/j.jad.2014.03.038. Epub 2014 Mar 31. J Affect Disord. 2014. PMID: 24767011

7

Evaluation of a clinical screening tool for HIV-associated sensory neuropathies.

Cherry CL, Wesselingh SL, Lal L, McArthur JC. Cherry CL, et al. Among authors: wesselingh sl. Neurology. 2005 Dec 13;65(11):1778-81. doi: 10.1212/01.wnl.0000187119.33075.41. Neurology. 2005. PMID: 16344522 Clinical Trial.

8

Tissue-specific associations between mitochondrial DNA levels and current treatment status in HIV-infected individuals.

Cherry CL, Nolan D, James IR, McKinnon EJ, Mallal SA, Gahan ME, Lal L, McArthur JC, Wesselingh SL. Cherry CL, et al. Among authors: wesselingh sl. J Acquir Immune Defic Syndr. 2006 Aug 1;42(4):435-40. doi: 10.1097/01.qai.0000224974.67962.ce. J Acquir Immune Defic Syndr. 2006. PMID: 16810110

9

Managing HIV. Part 3: Mechanisms of diseases. 3.7 How HIV leads to neurological disease.

Brew BJ, Wesselingh SL, Gonzales M, Heyes MP, Price RW. Brew BJ, et al. Among authors: wesselingh sl. Med J Aust. 1996 Feb 19;164(4):233-4. Med J Aust. 1996. PMID: 8604196 Review. No abstract available.

10

Increased adipocyte apoptosis in lipoatrophy improves within 48 weeks of switching patient therapy from Stavudine to abacavir or zidovudine.

Cherry CL, Lal L, Thompson KA, McLean CA, Ross LL, Hernandez J, Wesselingh SL, McComsey G. Cherry CL, et al. Among authors: wesselingh sl. J Acquir Immune Defic Syndr. 2005 Mar 1;38(3):263-7. J Acquir Immune Defic Syndr. 2005. PMID: 15735442

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

193 results

Search Page